Search
Close this search box.

BioVeda China Fund III

2014
Healthcare
China
BioVeda China Fund III: 
a case study about 
Healthcare 
in China

BioVeda China Fund III

2014
 | Healthcare
 | China
BioVeda China Fund III: 
a case study about 
Healthcare 
in China

In 2005, BioVeda China Fund (BVCF) Management Ltd became the first private equity firm specialized and dedicated to China’s healthcare and life sciences industries. BVCF supports Chinese entrepreneurs who are active in the development of innovative and affordable pharmaceutical products and services, and have a global scope. SIFEM invested in BVCF’s third fund, BVCF III, in 2014.

Links

Investment details: 
Company details: 

Latest News

SIFEM commits USD 15m to Jungle Ventures Fund V, a venture capital fund that will invest in impactful high-growth technology companies in Southeast Asia and India.

Latest News

SIFEM commits USD 15m to Jungle Ventures Fund V, a venture capital fund that will invest in impactful high-growth technology companies in Southeast Asia and India.